BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 11801559)

  • 1. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.
    Ueki K; Nishikawa R; Nakazato Y; Hirose T; Hirato J; Funada N; Fujimaki T; Hojo S; Kubo O; Ide T; Usui M; Ochiai C; Ito S; Takahashi H; Mukasa A; Asai A; Kirino T
    Clin Cancer Res; 2002 Jan; 8(1):196-201. PubMed ID: 11801559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p.
    Reifenberger J; Reifenberger G; Liu L; James CD; Wechsler W; Collins VP
    Am J Pathol; 1994 Nov; 145(5):1175-90. PubMed ID: 7977648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetic evidence for subtypes of oligoastrocytomas.
    Maintz D; Fiedler K; Koopmann J; Rollbrocker B; Nechev S; Lenartz D; Stangl AP; Louis DN; Schramm J; Wiestler OD; von Deimling A
    J Neuropathol Exp Neurol; 1997 Oct; 56(10):1098-104. PubMed ID: 9329453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.
    Cairncross JG; Ueki K; Zlatescu MC; Lisle DK; Finkelstein DM; Hammond RR; Silver JS; Stark PC; Macdonald DR; Ino Y; Ramsay DA; Louis DN
    J Natl Cancer Inst; 1998 Oct; 90(19):1473-9. PubMed ID: 9776413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma.
    Kraus JA; Koopmann J; Kaskel P; Maintz D; Brandner S; Schramm J; Louis DN; Wiestler OD; von Deimling A
    J Neuropathol Exp Neurol; 1995 Jan; 54(1):91-5. PubMed ID: 7815084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas.
    von Deimling A; Louis DN; von Ammon K; Petersen I; Wiestler OD; Seizinger BR
    Cancer Res; 1992 Aug; 52(15):4277-9. PubMed ID: 1353411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gliomas: association of histology and molecular genetic analysis of chromosomes 1p, 10q, and 19q.
    Gresner SM; Rieske P; Wozniak K; Piaskowski S; Jaskolski DJ; Skowronski W; Sikorska B; Papierz W; Liberski PP
    Acta Neurobiol Exp (Wars); 2007; 67(2):103-12. PubMed ID: 17691218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative molecular genetic profiles of anaplastic astrocytomas/glioblastomas multiforme and their subsequent recurrences.
    Saxena A; Shriml LM; Dean M; Ali IU
    Oncogene; 1999 Feb; 18(6):1385-90. PubMed ID: 10022821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas.
    Ichimura K; Pearson DM; Kocialkowski S; Bäcklund LM; Chan R; Jones DT; Collins VP
    Neuro Oncol; 2009 Aug; 11(4):341-7. PubMed ID: 19435942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormalities of p16, p15 and CDK4 genes in recurrent malignant astrocytomas.
    Saxena A; Robertson JT; Ali IU
    Oncogene; 1996 Aug; 13(3):661-4. PubMed ID: 8760309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.
    Lang FF; Miller DC; Koslow M; Newcomb EW
    J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of chromosomal changes by interphase cytogenetics in biopsies of recurrent astrocytomas and oligodendrogliomas.
    Rosso SM; van Dekken H; Krishnadath KK; Alers JC; Kros JM
    J Neuropathol Exp Neurol; 1997 Oct; 56(10):1125-31. PubMed ID: 9329456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of chromosome 1p/19q deletion by Fluorescence in Situ Hybridization (FISH) as prognostic factors in malignant glioma patients on treatment with alkylating chemotherapy.
    Pandith AA; Zahoor W; Manzoor U; Nisar S; Guru FR; Naikoo NA; Aein QU; Baba SM; Bhat AR; Ganai F; Shah P
    Cancer Genet; 2023 Nov; 278-279():55-61. PubMed ID: 37625215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progression-associated gene regions in astrocytomas: a candidate locus on chromosome 19q].
    von Deimling A; Albrecht S; Wiestler OD
    Verh Dtsch Ges Pathol; 1994; 78():423-6. PubMed ID: 7534013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct patterns of 1p and 19q alterations identify subtypes of human gliomas that have different prognoses.
    Vogazianou AP; Chan R; Bäcklund LM; Pearson DM; Liu L; Langford CF; Gregory SG; Collins VP; Ichimura K
    Neuro Oncol; 2010 Jul; 12(7):664-78. PubMed ID: 20164239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelic loss at 1p and 19q frequently occurs in association and may represent early oncogenic events in oligodendroglial tumors.
    Bello MJ; Leone PE; Vaquero J; de Campos JM; Kusak ME; Sarasa JL; Pestaña A; Rey JA
    Int J Cancer; 1995 Jun; 64(3):207-10. PubMed ID: 7622310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of chromosome 1 abnormalities in human gliomas reveals frequent loss of 1p in oligodendroglial tumors.
    Bello MJ; Vaquero J; de Campos JM; Kusak ME; Sarasa JL; Saez-Castresana J; Pestana A; Rey JA
    Int J Cancer; 1994 Apr; 57(2):172-5. PubMed ID: 8157354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of cytogenetic analysis and loss of heterozygosity studies in human diffuse astrocytomas and mixed oligo-astrocytomas.
    Ransom DT; Ritland SR; Moertel CA; Dahl RJ; O'Fallon JR; Scheithauer BW; Kimmel DW; Kelly PJ; Olopade OI; Diaz MO
    Genes Chromosomes Cancer; 1992 Nov; 5(4):357-74. PubMed ID: 1283325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human glioblastomas with no alterations of the CDKN2A (p16INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene.
    Ichimura K; Schmidt EE; Goike HM; Collins VP
    Oncogene; 1996 Sep; 13(5):1065-72. PubMed ID: 8806696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hsp27 (HSPB1): a possible surrogate molecular marker for loss of heterozygosity (LOH) of chromosome 1p in oligodendrogliomas but not in astrocytomas.
    Castro GN; Cayado-Gutiérrez N; Moncalero VL; Lima P; De Angelis RL; Chávez V; Cuello-Carrión FD; Ciocca DR
    Cell Stress Chaperones; 2012 Nov; 17(6):779-90. PubMed ID: 22806482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.